Mather Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
VCM
VPM
Mather Group's GILD Position: Q1 2026 in Review
Mather Group increased its Gilead Sciences (GILD) stake by 109% in Q1 2026, buying an estimated $2.47M and bringing the position to 33,888 shares worth $4.72M. The position accounts for 0.05% of the portfolio, ranked #140.
Mather Group first reported a position in GILD in Q3 2022 and has held it in 15 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- Mather Group held 33,888 shares of Gilead Sciences worth $4.72M as of Q1 2026.
- Mather Group bought 17,652 Gilead Sciences shares in Q1 2026, an estimated $2.47M.
- Gilead Sciences made up 0.05% of Mather Group's portfolio in Q1 2026, its #140 holding.
- Mather Group first reported a position in Gilead Sciences in Q3 2022 and has held it in 15 quarters since.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on Mather Group's 13F filing for Q1 2026, filed 13 Apr 2026.